Longtime drug official
Pazdur spent three weeks as head of a key drug approval division before suddenly announcing plans to resign on Tuesday. In a private conversation on Wednesday with Kennedy, Pazdur said he had misgivings about Commissioner
Pazdur’s issues included policy initiatives ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
